Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Recruiting 3Terminated 2Completed 2Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Gastrointestinal 3CNS 3Sarcoma 2Thoracic 1Head & Neck 1Endocrine 1Breast 1

Conditions

Pancreatic Neoplasms 1Gastroesophageal Junction Adenocarcinoma 1Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1

Interventions

Oxaliplatin 197Bevacizumab 162Fluorouracil 155Capecitabine 137Gemcitabine 133Leucovorin 112pembrolizumab 99Cisplatin 93Drug Therapy 89Irinotecan 81Radiotherapy 73sintilimab 70durvalumab 65130-nm albumin-bound paclitaxel 65Paclitaxel 64Specimen Handling 62Cetuximab 61lenvatinib 59tislelizumab 58Nivolumab 55Magnetic Resonance Spectroscopy 55Folfox protocol 55Blood Specimen Collection 52atezolizumab 48Biopsy 46Surgical Procedures, Operative 40Taxes 38Albumin-Bound Paclitaxel 38Immune Checkpoint Inhibitors 37HMPL-013 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Protons × Gastrointestinal × Clear all
NCT03801876 2026-05-07

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

NRG Oncology

Phase 3 Recruiting
300 enrolled
Gastrointestinal

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

NCT04894643 2026-03-20

PARC

EBG MedAustron GmbH

Phase NA Recruiting
10 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04656041 2025-11-14

Folfox+Irinotecan+Chemort In Esophageal Cancer

Massachusetts General Hospital

Phase 2 Recruiting
40 enrolled
Gastrointestinal

Gastroesophageal Junction Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡